Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Daniella Pena"'
Autor:
Daniel H. Saris, Daniella Pena, Ashley F. Haggerty, Neil K. Taunk, Emily M. Ko, Anna Jo Bodurtha Smith
Publikováno v:
Gynecologic Oncology Reports, Vol 47, Iss , Pp 101177- (2023)
Delays in starting potentially curative treatment for locally-advanced cervical cancer (LACC) decrease survival. Reasons for these delays are poorly understood. We conducted a retrospective chart review examining disparities in time from diagnosis of
Externí odkaz:
https://doaj.org/article/58413237d11f4835b93ce5c0ef747a59
Autor:
Anna Jo Bodurtha Smith, Lakeisha Mulugeta-Gordon, Daniella Pena, Genevieve P. Kanter, Justin E. Bekelman, Ashley Haggerty, Emily M. Ko
Publikováno v:
Gynecologic Oncology Reports, Vol 46, Iss , Pp 101159- (2023)
While prior authorization aims to reduce unnecessary care, it may limit or delay medically necessary care. Delays in cancer care can impact survival and are more common in historically-marginalized populations. Our objective was to examine to what ex
Externí odkaz:
https://doaj.org/article/e2454eec443542299513e7d7c7d54355
Autor:
Anna Jo Bodurtha, Smith, Lakeisha, Mulugeta-Gordon, Daniella, Pena, Genevieve P, Kanter, Justin E, Bekelman, Ashley E, Haggerty, Emily M, Ko
Publikováno v:
Gynecologic Oncology. 167:519-522
Prior authorization was designed to minimize unnecessary care and reduce spending but has been associated with delays in necessary care. Our objective was to estimate the occurrence of prior authorization, and impact on cancer care, in gynecologic on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7887a0aea5e941e71167037f754ba872
https://doi.org/10.1016/j.ygyno.2022.10.002
https://doi.org/10.1016/j.ygyno.2022.10.002
Publikováno v:
Gynecologic Oncology. 166:S285-S286
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aca79d996c11c216cab338cc43633337
https://doi.org/10.1016/s0090-8258(22)01809-1
https://doi.org/10.1016/s0090-8258(22)01809-1
Autor:
Anna Jo Smith, Lakeisha Mulugeta-Gordon, Daniella Pena, Genevieve Kanter, Justin Bekelman, Ashley Haggerty, Emily Ko
Publikováno v:
Gynecologic Oncology. 166:S85
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c054b8d62c3ec4b6c1e0c90e4c5f4d7
https://doi.org/10.1016/s0090-8258(22)01362-2
https://doi.org/10.1016/s0090-8258(22)01362-2
Publikováno v:
Journal of Clinical Oncology. 40:5549-5549
5549 Background: PARP inhibitors improve survival in ovarian cancer, especially in patients with BRCA 1/2 mutations or homologous recombination deficiency (HRD). However, these FDA-approved drugs cost $100,000 annually on average, and concerns have b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ad26bd0e8aaf6112e140faf93b9bb8d
https://doi.org/10.1200/jco.2022.40.16_suppl.5549
https://doi.org/10.1200/jco.2022.40.16_suppl.5549
Publikováno v:
OMEGA - Journal of Death and Dying. 51:337-342
Male/female differences in aging-related issues may extend beyond individuals' actual lives. Gender differences in 869 obituaries, death notices, and memorials were examined. Males, compared to females, had significantly more lines describing careers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86ae324ed6912d03d55a334592860bed
https://doi.org/10.2190/v443-74pw-7066-0173
https://doi.org/10.2190/v443-74pw-7066-0173